Search by Drug Name or NDC
NDC 00703-5075-03 Dacarbazine 200 mg/20mL Details
Dacarbazine 200 mg/20mL
Dacarbazine is a INTRAVENOUS INJECTION, POWDER, FOR SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Teva Parenteral Medicines, Inc.. The primary component is DACARBAZINE.
MedlinePlus Drug Summary
Dacarbazine is used to treat melanoma (a type of skin cancer) that has spread to other parts of your body. Dacarbazine is also used in combination with other medications to treat Hodgkin's lymphoma (Hodgkin's disease; a type of cancer that begins in a type of white blood cells that normally fights infection). Dacarbazine is in a class of medications known as purine analogs. It works by slowing or stopping the growth of cancer cells in your body.
Related Packages: 00703-5075-03Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Dacarbazine
Product Information
| NDC | 00703-5075 |
|---|---|
| Product ID | 0703-5075_46f32b94-ccdf-42ce-a41c-60f929479db8 |
| Associated GPIs | 21700020002110 |
| GCN Sequence Number | 008834 |
| GCN Sequence Number Description | dacarbazine VIAL 200 MG INTRAVEN |
| HIC3 | V1F |
| HIC3 Description | ANTINEOPLASTICS,MISCELLANEOUS |
| GCN | 38731 |
| HICL Sequence Number | 003927 |
| HICL Sequence Number Description | DACARBAZINE |
| Brand/Generic | Generic |
| Proprietary Name | Dacarbazine |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Dacarbazine |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, POWDER, FOR SOLUTION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 200 |
| Active Ingredient Units | mg/20mL |
| Substance Name | DACARBAZINE |
| Labeler Name | Teva Parenteral Medicines, Inc. |
| Pharmaceutical Class | Alkylating Activity [MoA], Alkylating Drug [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA075259 |
| Listing Certified Through | n/a |
Package
NDC 00703-5075-03 (00703507503)
| NDC Package Code | 0703-5075-03 |
|---|---|
| Billing NDC | 00703507503 |
| Package | 10 VIAL, SINGLE-DOSE in 1 TRAY (0703-5075-03) / 20 mL in 1 VIAL, SINGLE-DOSE |
| Marketing Start Date | 1998-08-27 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |